Zydus Pharmaceuticals (USA) Inc. is recalling 3,144 bottles of chlorproMAZINE Hydrochloride Tablets (10 mg), a medication used to treat certain mental/mood disorders and severe nausea. The recall was initiated because testing detected an impurity called N-Nitroso-Desmethyl Chlorpromazine at levels exceeding the recommended interim limit. This recall affects 100-count bottles distributed across 18 states.
The presence of nitrosamine impurities above acceptable limits may increase the risk of cancer if consumed over a long period of time. There are currently no reports of adverse events related to this recall.
You have 2 options:
Manufactured by: Zydus Lifesciences Ltd., Baddi, India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.